The recent significant penalty imposed on Medtronic sends a strong warning to companies supplying therapeutic goods in Australia. It reinforces the central position of the Australian Register of ...

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

SYDNEY, Nov 3 (Reuters) - Australian Prime Minister Anthony Albanese said on Sunday that his government planned to cut student loans for around three million Australians by 20%, wiping off around ...

Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera Mapping and Ablation ...

Merck's key growth driver is facing headwinds, but the company should get over the hump. Medtronic has a diversified business and several important growth avenues. Merck isn't having a good year ...

SYDNEY, Nov 5 (Reuters) - Australia's central bank held interest rates steady on Tuesday, as expected, and cautioned policy would need to stay restrictive for some time yet, strongly suggesting ...

Medtronic (MDT) closed at $91.12 in the latest trading session, marking a +0.1% move from the prior day. The stock exceeded the S&P 500, which registered a loss of 0.05% for the day. Elsewhere ...

Editorial note: Forbes Advisor Australia may earn revenue from this story in the manner disclosed here. Read our advice disclaimer here. Australia’s mid-sized capitals are the clear stand-outs ...

Editorial note: Forbes Advisor Australia may earn revenue from this story in the manner disclosed here. Read our advice disclaimer here. Australia’s annual inflation rate has fallen to its ...

Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s greenlight for its Affera mapping and ablation system with the Sphere-9 catheter.

Here’s how it works. The end of the year is here, so the best streaming services in Australia are set to drop some yuletide cheer this November. With some seriously silly holiday movies ...